NuVasive Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
NuVasive (NUVA) Announces New Organizational Structure; COO, CFO Resign
July 27, 2017 5:17 PM EDTNuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced a new organizational structure to drive the Company's growth and profitability goals, supporting its strategy to help deliver safer, more predictable spine surgery.
"As the innovation pioneer and largest, pure-play spine technology company, NuVasive continues to deliver significant value to its customers and shareholders," said Gregory T. Lucier, NuVasive's chairman and chief executive officer. "With incredible opportunities ahead, we are taking steps to refine the company's operating structure to tightly align strategy,... More
NuVasive (NUVA) Tops Q2 EPS by 2c
July 27, 2017 4:49 PM EDTNuVasive (NASDAQ: NUVA) reported Q2 EPS of $0.46, $0.02 better than the analyst estimate of $0.44. Revenue for the quarter came in at $260.6 million versus the consensus estimate of $262.22 million.
For earnings history and earnings-related data on NuVasive (NUVA) click here.
... More